U.S. Patent Number
Biosafety Level 2

Biosafety  classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Zoopathogenic. This holding (VR-2128), VR-2167 and VR-2126 are attenuated derivatives of VR-2125, FIPV 79-1146. Patent deposit.
Cross reacts with canine coronavirus, TGE virus of swine and Human coronavirus 229E. For background information see Pederson et al. (1984: Adv. Exp. Med. Biol., 173: 365-380) and U.S. Patent No. 4,195,130.
Shipped frozen
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished.
Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation

Pedersen NC, et al. Pathogenicity studies of feline coronavirus isolates 79-1146 and 79-1683. Am. J. Vet. Res. 45: 2580-2585, 1984. PubMed: 6084432

McKeirnan AJ, et al. Isolation of Feline Coronaviruses from Two Cats with Diverse Disease Manifestations. Feline Pract. 11: 16-20, 1981.

Baldwin CA, Scott FW. Feline infectious peritonitis vaccine and method of preparation. US Patent 5,043,157 dated Aug 27 1991